NAN vs OCC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

52MEDIUM

OCC

ORTHOCELL FPO [OCC]

52MEDIUM

Score Breakdown

NAN OCC
Technical
49
45
Catalyst
53
55
Sentiment
50
50
Fundamental
94
83
Momentum
41
50
Risk Gate
40
45

Key Metrics

NAN Metric OCC
$965.5MMarket Cap$222.8M
440KAvg Volume (20d)527K
+6.9%Short Interest+0.4%
$4.77052-Week High$1.600
$2.96052-Week Low$0.700
-0.3%Daily Change-6.5%
$3.220Entry Price$0.795
+10.1%ROE-41.1%
+9.9%Profit Margin-133.8%

Active Signals

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

OCC Signals

●Drifting lower — down 5.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●4C filed 2026-07-12
●Strong revenue growth (+49%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (13% of range)

Ask Scout AI to compare NAN and OCC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NAN Full Analysis → OCC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).